San Antonio Express-News – OxyContin maker Purdue Pharma has reportedly offered to settle, for a combined $10 billion to $12 billion, more than 2,000 lawsuits alleging deceptive marketing by the Stamford-based company and the Sackler family members who own the firm.
Robert Bird
New data doesn’t dispel legal pressure for OxyContin maker Purdue
Stamford Advocate – OxyContin maker Purdue Pharma accounted for about 3 percent of the prescription opioids produced in the U.S. between 2006 and 2012, according to newly released federal data — but the disclosure of the small market share is unlikely to tamp down the intense legal pressure from the state of Connecticut and hundreds of other plaintiffs.
Business Law Professor Vincent Carrafiello Dies at 78
Beloved business law professor Vincent Carrafiello, a two-time alumnus who devoted 52 years to educating UConn students, passed away on Saturday at age 78.Continue Reading
Business Law Experts: Our Knowledge Is Critical for CEOs
When 60 thought leaders in business-law education gathered at UConn’s graduate campus in Hartford last week to look at the future of their profession, there was one message that resonated with all:
Never has there been a more critical time for legal education to be embraced as a fundamental part of a high-quality business-education curriculum.Continue Reading
Purdue Pharma bypasses state drug monitoring
Lawsuit: Sackler Emails ‘Shocking and Offensive’ to Opioid Victims
CT Post – Connecticut Attorney General William Tong released Tuesday an unredacted version of the state’s lawsuit against OxyContin maker Purdue Pharma, revealing emails from 2001 that he said showed company co-owner and former CEO and President Richard Sackler’s “shocking and offensive” disregard for victims of the opioid crisis — an assertion contested by Sackler’s attorney.